Nanrilkefusp Alfa
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nanrilkefusp Alfa, covering 2025-07-24 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]